secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENZO BIOCHEM INC (—)
CIK:        0000316253
Form:       8-K
Filed at:   2025-01-14T23:59:59+00:00
Accession:  0001213900-25-003421
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enzo Biochem receives NYSE non-compliance notices for low market cap & stock price
--------------------------------------------------------------------------------

- NYSE notified Enzo of non-compliance due to 30-day avg market cap <$50M and equity <$50M (Oct 31, 2024).
- Additionally, average closing price of ENZ common stock was <$1.00 over consecutive 30 trading days.
- Company has 18 months to cure market cap/equity deficiency and 6 months to cure price deficiency.
- Enzo will notify NYSE by Jan 23, 2025 and submit a compliance plan by Feb 21, 2025.
- Common stock continues to trade on NYSE subject to other listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/316253/000121390025003421/0001213900-25-003421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/316253/000121390025003421/ea022765801-8k_enzobiochem.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-003421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer